Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • issue 2-3
  • >
  • Alprazolam (Xanax) w leczeniu zaburzeń lękowych – Doświadczenia Kliniki Psychiatrycznej we Wrocławiu

Archive 1995–2023

1995, volume 11, issue 2-3
Article

Alprazolam (Xanax) w leczeniu zaburzeń lękowych – Doświadczenia Kliniki Psychiatrycznej we Wrocławiu

Farmakoterapia w Psychiatrii i Neurologii, 1995, 2-3, 43-50
Summary

Alprazolam as the benzodiazepin preparation, possessing in its chemical structure a triazol ring, by its typical antianxiety (anxiolitic) influences, characterises in antidepressive effect. The purpose of the study led simultaneously in some Polish centers was to estimate clinical efficacy and safety of therapy. Researches in Wrocław were led in 24 patients with a diagnosis of generalized anxiety disorder (GAD), with concomitant depressive symptoms during six weeks lasting treatment with precise range of the dosage. Anxiolitical activity of Xanax significantly manifested after 1 week therapy by a daily dose of about 2 mg and was parallel to an antidepressive effect. Therapeutical effect appeared for a whole period of serving the medicine and wasn't accompanied with serious side symptoms.

You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links